Joshua D. Schein
Vorstandsvorsitzender bei Lev Development Corp.
Profil
Joshua D.
Schein is the founder of Callisto Pharmaceuticals, Inc. (founded in 2003).
Dr. Schein is also the founder of HEMOxymed, Inc...
Dr. Schein's current job(s) include being the Chief Executive Officer at Lev Development Corp.
(since 2003), a Principal at Prism Ventures LLC (since 1997), and a Partner at Prism Venture Management LLC.
Dr. Schein's former job(s) include being the Chief Executive Officer & Secretary at SIGA Technologies, Inc. (from 1995 to 2001), the Chief Executive Officer at Lev Pharmaceuticals, Inc., a Director & Executive Officer at Virologix Corp.
(from 1996 to 1998), a Director at Assertio Therapeutics, Inc. (from 1995 to 1998), and a Director & Executive Officer at Callisto Pharmaceuticals, Inc. (from 1996 to 1998).
Dr. Schein's education history includes an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from Brandeis University, and a doctorate from Yeshiva University.
Aktive Positionen von Joshua D. Schein
| Unternehmen | Position | Beginn |
|---|---|---|
| Lev Development Corp. | Vorstandsvorsitzender | 01.07.2003 |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Joshua D. Schein
| Unternehmen | Position | Ende |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Präsident | 01.04.2001 |
| Virologix Corp. | Direktor/Vorstandsmitglied | 01.08.1998 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Direktor/Vorstandsmitglied | 01.06.1998 |
| Josephthal & Co (Broker) | Corporate Officer/Principal | 01.01.1995 |
| HEMOxymed, Inc. | Corporate Officer/Principal | - |
Ausbildung von Joshua D. Schein
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Brandeis University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | Health Technology |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Virologix Corp. | Health Technology |
| Josephthal & Co (Broker) | Finance |
| Lev Development Corp. | |
| HEMOxymed, Inc. | Health Technology |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Finance |
